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ABSTRACT
Biological exposures to micro- and nano-scale exogenous metal particles generated as a 
consequence of in-service degradation of orthopaedic prosthetics can result in severe adverse 
tissues reactions. However, individual reactions are highly variable and are not easily predicted, 
due to in part a lack of understanding of the speciation of the metal-stimuli which dictates 
cellular interactions and toxicity. Investigating the chemistry of implant derived metallic 
particles in biological tissue samples is complicated by small feature sizes, low concentrations 
and often a heterogeneous speciation and distribution. These challenges were addressed by 
developing a multi-scale two-dimensional X-ray absorption spectroscopic (XAS) mapping 
approach to discriminate sub-micron changes in particulate chemistry within ex-vivo tissues 
associated with failed CoCrMo total hip replacements (THRs). As a result, in the context of 
THRs, we demonstrate much greater variation in Cr chemistry within tissues compared with 
previous reports. Cr compounds including phosphate, hydroxide, oxide, metal and organic 
complexes were observed and correlated with Co and Mo distributions. This variability may 
help explain the lack of agreement between biological responses observed in experimental 
exposure models and clinical outcomes. The multi-scale 2D XAS mapping approach presents 
an essential tool in discriminating the chemistry in dilute biological systems where speciation 
heterogeneity is expected.
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1. INTRODUCTION
The presence of exogenous metallic microparticles, nanoparticles, complexes and ions in 
biological systems is of great interest to human health. Exposures may be inadvertent, through 
ingestion, inhalation or surface absorption routes. [1-3] Alternatively, metal-species may be 
introduced for therapeutic, diagnostic or cosmetic applications, or generated in-situ as a result 
of the degradation of an implanted prosthesis or device. [4-6] The biological significance of an 
exposure is dictated by both the physico-chemical nature of the metal, the location of the 
exposure and by the host organism's physiological response, which will differ between 
individual subjects. [3, 7] Factors influencing biological reactivity include the size, [8, 9] 
morphology, [10, 11] composition, [12] solubility, [3] surface charge and distribution of metallic 
particles [13, 14] and the local concentration and binding affinity of ions. [15] The chemical species 
in which an exogenous metal presents, and its stability within a specific physiological 
environment dictates many of these factors and therefore influences the biological outcome. An 
exposure route of increasing significance to healthcare, is the degradation of metal implant 
surfaces leading to the in-situ release of micro- and nano-sized metal particles and soluble ions. 
[10, 16] In particular, the release of metallic implant derivatives from orthopaedic total joint 
replacements has been associated with osteolytic activity and implant loosening. [17-20] A lack 
of understanding of the complex nature of the metal-species formed, and how these species may 
be further transformed within biological media, has prevented the translation of findings from 
in-vitro biological modelling efforts, into informed clinical monitoring and assessment of 
individual risk. In this work, a novel multi-scale chemical imaging approach is applied to tissues 
associated with failing total-hip-replacement (THRs), shedding light on the hereto unreported 
heterogeneity in speciation of the micron and nano-sized debris formed. 
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Many studies have attempted to correlate concentrations of exogenous elements in tissues and 
fluids with a biological response. However, subtle variability in metal speciation may be a 
significant confounder when interpreting these data. For example, certain endogenous 
complexes of trivalent Cr (Cr(III)) are involved in glucose metabolism, however hexavalent Cr 
(Cr(VI)) is a group 1 carcinogen. [21, 22] Similarly, different Nickel (II) salts, Co compounds and 
structural polymorphs of Titanium dioxide, detected in biological systems, demonstrate 
significant differences in cellular cytotoxicity and genotoxicity. [21, 23-26] To fully understand the 
implications of an exposure, the local chemistry of the metals directly involved in the biological 
interactions must be known. Characterisation is complicated by the dynamic nature of 
biomolecules adsorbing to particles resulting in complexes which change depending on their 
local environment. [27] This highlights the importance of maintaining an appropriate 
environment during characterisation in order to preserve the in-situ chemical form.
The chemistry of small particles at the micron and nanometric scale is especially difficult to 
identify as most characterisation techniques routinely applied to ex-vivo tissue analysis, provide 
bulk chemical information failing to distinguish differences between the particle core and 
surface. In addition, these particles are often found as nano- or micro- sized agglomerates at 
trace levels heterogeneously distributed throughout the sample. [28, 29] Therefore the analytical 
technique must provide adequate detection limits, with a high spatial resolution, and be able to 
interrogate the composition and chemistry over a relevant field of view in a non-destructive 
manner. Diffraction based methods do not possess the required sensitivities to interrogate these 
types of systems, and mass spectrometry techniques are destructive and lack sufficient spatial 
resolution. [30] Samples for electron microprobes must be dehydrated, which may influence the 
natural chemical form and typically have severely restricted fields of view with lower 
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sensitivities in comparison to other interrogation sources. [31] Proton or particle probes can be 
utilized to investigate the chemical composition using Particle Induced X-ray Emission (PIXE). 
[32] However, X-ray sources can be used to map the elemental distribution (X-ray Fluorescence 
Spectroscopy) whilst giving an insight into the chemistry (X-ray Absorption Spectroscopy). [32, 
33] High flux X-ray micro and nano probes are widely used to interrogate exogenous features 
within biological samples due to their detection limits, spatial resolution and flexibility of the 
sample environment which enables measurements to be conducted on dehydrated tissues and 
where required, on hydrated tissues under cryogenic conditions. 
X-ray absorption near edge structure (XANES) can be used to determine the oxidation state, 
coordination number, covalence and the symmetry of the metal particles. [34] Conventional 
XANES methods interrogate the absorption coefficient by scanning through carefully selected 
X-ray energies at a single point within the sample. This has previously been used to identify 
different metallic species within tissues exposed to THR systems. [35, 36] Whilst these studies 
may show the predominate species present, what is often neglected is the full chemical variation 
present, due to the interrogation method. In samples where speciation heterogeneity on length 
scales smaller than the resolution of the X-ray beam are present, the resultant spectrum is a 
weight sum of these species. These may be difficult to segment in scenarios with several species 
with similar spectral features. To improve chemical identification a higher resolution source 
may be used. However, significant problems arise in XANES measurements when the X-ray 
beam size approximates the dimensions of the interrogated features. Subtle movements in the 
sample (due to local heating) or beam position (instability in the optics) results in the X-ray 
beam drifting off the feature, which in turn generates uninterpretable data. [37] This scenario is 
often the case when investigating metallic particles in biological tissues, as they contain many 
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isolated features which limits the available areas for spectroscopic analyses. A multi-scale 
XANES mapping approach can be used to reduce these associated limitations. [37, 38] 
Recently the acquisition of fluorescence energy maps (XANES maps) has become prevalent on 
hard X-ray micro- and nano- probes to investigate the speciation of dilute elements spatially. 
XANES mapping involves mapping in three axes, two image axes and one energy. 
Conventionally, the energy is the outer axis whereby a series of XRF maps are recorded at 
specific energy values corresponding to the absorption edge of the target element. These are 
subsequently stacked to produce an individual spectrum for each pixel. Recently, Bosenberg et 
al used the energy as the inner axis to collect XANES images by using a QEXAFS 
monochromator. Whilst this has significantly advantages when investigating transient species, 
there is no straight forward method of correcting beam/sample drift. [39] This correction is 
essential when XANES mapping exogenous particles in soft tissues which are susceptible to 
movement. XANES mapping results in a chemical image containing spectroscopic information 
within a 2-dimensional field. This adds additional information regarding the chemistry of the 
system over a user defined area, which may be useful for co-locative studies. Isolated features 
which previously could not be identified spectroscopically can be investigated with the use of 
post-analytical stack alignments, which alleviate the effects caused by movement. [40]
It is hypothesized that conventional XANES methods at an inappropriate resolution, limits the 
number of species identifiable in ex-vivo tissues that once surrounded CoCrMo THRs. By using 
a multi-scale XANES mapping approach it is anticipated that better speciation discrimination 
will be achieved, ultimately allowing for more accurate characterisation of local chemistry. To 
our knowledge here for the first time a multi-scale XANES mapping approach has been applied 
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to investigate the speciation of metallic debris within such tissues. By using this approach, the 
entire chemical variability was assessed on different length scales, enabling samples containing 
heterogeneous species to be better identified. In addition, isolated small features renowned for 
producing poor static XANES measurements were interrogated with the aid of post analytical 
alignment. 
2. MATERIALS AND METHODS
Synovial sheath tissues were taken at the time of scheduled revision surgery of CoCrMo THRs 
from two consenting patients who exhibited similar device histories, implant bearing surfaces 
(metal-on-metal), and alloy composition (ASTM grades F75 and F799 (58.9 - 69.5% Co, 27.0 
- 30.0% Cr, 5.0 - 7.0% Mo). [41] The patients underwent revision of a CoCr R3 Acetabular cup 
Synergy Hip stem combination (Smith and Nephew, UK), and a Birmingham Hip Resurfacing 
(Smith and Nephew, UK) after 6.5 and 6 years, respectively. For both patients the reason for 
revision was a prosthesis associated joint effusion with elevated systemic implant ion levels. 
Retrieved tissue explants were orientated, immediately placed on dry ice for transfer and then 
stored at -80°C at a Human Biomaterials Resource Centre approved site at the University of 
Birmingham (ethical approval REC 09/H1010/75). Serial frozen tissue sections between 4-8 
μm in thickness were prepared using a cryotome with a tungsten carbide blade. Sections were 
mounted on silicon nitride membranes (Silson Ltd, UK) or Ultralene (SPEX®SamplePrep, 
USA). Tissues were interrogated at the following beamlines: I18 (microfocus spectroscopy 
beamline) and I14 (hard X-ray Nanoprobe), Diamond Light Source (Harwell Science and 
Innovation Campus, UK). ID21 (X-ray microscope beamline), European Synchrotron Radiation 
Facility (Grenoble, France). X05LA (MicroXAS beamline), Swiss Light source (Villigen, 
Switzerland). I18 utilises a Kirkpatrick-Baez (KB) mirror system to focus the beam into the 
micron range and uses a liquid nitrogen cooled Si(111) monochromator to cycle through the 
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required energies. [42, 43] X-ray fluorescence maps were produced using an incident energy of 
8.5 keV, which allowed detection of elements Co down to Cl. Samples were mounted onto 
Ultralene and positioned 45° to the incident source. With the mounting angle taken into 
consideration the beam was focused down to a foot-print size of 3 x 3 μm. An acquisition time 
of 200 ms per pixel was used, and the signal was acquired with a 4-element Vortex Si drift 
detector (Hitachi Hi-Technologies Science, Tokyo). A step size of 3 μm was used for both 
horizontal and vertical movement. Measurements were undertaken at room temperature. Two 
large XRF maps were acquired on a single tissue section, both of which had similar implant-
related metal distributions. A total of 91 sequential energy points were chosen to produce 
XANES maps (Supplementary Table 1). To interrogate at a higher resolution, the tissues were 
mounted onto Silicon Nitride membranes and taken to the scanning X-ray microscope end-
station on ID21 at the European Synchrotron Radiation Facility (Grenoble, France). [44] ID21 
uses a fixed exit double crystal Si(111) monochromator to select and scan the energy of the 
beam. This is then focused using a KB mirror system. Measurements are made using an energy 
dispersive detector; a silicon drift diode (SGX Sensortech, Switzerland). Measurements were 
undertaken at room temperature under a vacuum. The X-ray beam was focused to a footprint 
of 600 x 300 nm (H x V) and an incident energy of 7.8 keV was used to allow detection of Co 
and Cr. An acquisition time of 100 ms was used per pixel. A second energy of 6 keV was 
utilized to re-measure the  same area to generate a better signal-to-noise ratio on low Z-elements 
found in tissues. This energy was chosen to still allow detection of Cr to assess whether an 
image shift had occurred, as changing the monochromator Bragg angle may have caused a 
movement of the beam position. No shift in the Cr signals was detected and as a result no 
alignment was necessary between the 7.8 and 6 keV maps. Samples were mounted on Silicon 
Nitride membranes and imaged in vacuum. A total of 11 (83 x 83 µm) XRF maps were 
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generated by imaging three tissue serial sections for matched patient tissues interrogated at I18. 
To produce fluorescence XANES maps a total of 117 sequential energy points were chosen, the 
energy values can be found in Supplementary Table 1.
To detect the presence of Mo, the tissues were taken to the MicroXAS beamline at the Swiss 
Light Source (Villigen, Switzerland). Similar to I18 a KB mirror system was utilized to focus 
the X-ray beam to a footprint of 1 x 1 μm. An incident energy of 20.5 keV allowed the detection 
of Molybdenum. An acquisition time of 5 s per pixel was used to generate adequate statistics, 
and a multi-element Si solid state detector (Ketek, Germany) was used to collect the 
fluorescence signal. The chemistry of both Co and Cr were interrogated at the hard X-ray 
nanoprobe I14 at Diamond Light Source. Samples were mounted onto Silicon Nitride 
membranes and an incident energy of 9.2 keV was selected using a horizontal double crystal 
monochromator. The X-ray beam was focused using a KB mirror system to a footprint of 250 
x 250 nm. XRF maps were acquired using a 4-element Si drift detector (Rayspec, UK) with an 
acquisition time of 100 ms per pixel. Measurements were undertaken at room temperature. A 
single fluorescence map, with resolution of 1 µm, imaged on a serial section matched those 
imaged at I18 and ID21. Two higher resolution (250 nm) were subsequently imaged at regions 
of interest within the lower resolution map. Fluorescence XANES map were recorded for Co 
and Cr K-edge using 118 and 125 energy points respectively (Supplementary Table 1).
XRF maps collected from all beamlines were batch fitted using PyMCA. This software fits the 
fluorescent lines along with a background subtraction pixel by pixel. [45] The fluorescent maps 
are shown as RGB images to allow clear visual co-locative representation of the metallic 
distribution throughout the tissue. Where the Co: Cr ratio map is shown in Figure 6b, the XRF 
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data was assessed semi-quantitatively. This was achieved by applying a matrix correction 
(based on a soft tissue composition) and considering excitation efficiencies calculated in 
PyMCAs inbuilt quantification algorithms. [45, 46]
The XANES map data were stacked, aligned and windowed at the emission energy of the 
element of interest (±200 eV). Alignment was conducted using MANTiS for the data collected 
at Diamond Light Source and inhouse scripts, based on Python and PyMCA tools, was utilized 
for the data collected at the ESRF. [47, 48] Principle components (PCs) analysis and cluster 
analysis was undertaken on the XANES stacks. Before analysis each spectrum was normalized 
by dividing the intensity value by the last energy point. This is important as this eliminates PCs 
based on intensity rather than spectral differences. Clustered spectra were generated based on 
the PCs. The grouped spectra were normalized using software package ATHENA. [49] The 
spectra were compared against standards and linear combination fitting was attempted to 
reproduce the experimental data with combinations of standards. Linear regression analysis was 
used to cross-correlate XANES spectra acquired using different measurement approaches 
including comparison of point spectra, mapping spectra and spectra acquired at different spatial 
resolutions.
3. RESULTS AND DISCUSSION
3.1. Micro- XAFS/XRF measurements (3 μm resolution)
Ex-vivo peri-implant tissue was retrieved at the time of revision surgery from patients with 
CoCrMo THRs and was interrogated with μXRF and μXAFS. A representative μXRF image is 
shown in Figure 1a. The fluorescence intensity map shows an accumulation of Co and Cr 
following the tissue planes of the synovial sheath, with high intensity features of Co and Cr co-
located surrounded by lower intensity regions of Cr. The co-location of Mo with high intensity 
Co and Cr identifies regions most closely matching the composition of the base metal 
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(Supplementary Figure 1). The distribution in fluorescence intensity of Co and Cr is consistent 
with previous reports. [50] The quantitative values are summarised in Supplementary Table 2. 
Whilst the average concentration of Co and Cr within these tissues is similar to previous reports 
[35, 36], the localised maximum concentrations are significantly higher. This heterogeneity in 
concentration is typically not detected by non-spatially resolved techniques such as mass 
spectrometry performed bulk on samples, but is essential to understand in the context of a 
biological response. A Cr K-edge XANES spectrum was recorded on a large feature possessing 
a high intensity signal, shown in Figure 1b. This area was selected to generate high quality data, 
a rationale adopted by many researchers. [36, 51] However the selection method introduces bias 
sampling as the region with the highest intensity may not be representative speciation of the 
entire area. The spectrum shown in Figure 1b displays features characteristic of hydrated Cr 
phosphate (CrPO4), which has been previously reported when adopting the same interrogation 
methods on similar tissues. [35, 50] Undertaking spectroscopic measurements, mapping or point 
XANES, is undoubtedly limited by the intensity of the feature. In practice there must be a 
distinct detectable fluorescence peak above the noise limits to be constructed into a fluorescence 
XANES spectrum. Primarily, factors which influence this intensity are sample related 
(concentration of element of interest) and instrumental set-up (flux, solid angle, detector 
efficiency etc.). Regardless of employing a mapping or static measurement method, both are 
limited to the same detection limits. However, isolated features possessing adequate intensity 
often produce poor quality point measurements, due to movement related drawbacks as 
previously mentioned. A mapping approach can significantly improve the gathering of 
spectroscopic information on such features.
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Figure 1. μXRF and µXANES analysis was undertaken at I18, Diamond Light Source, UK.  (a) shows 
an XRF map of ex-vivo synovial sheath tissue, Cl (green) is a typical tissue marker and shows the 
geometry. Co and Cr (red and blue respectively) are co-located in areas but Cr appears more abundantly 
and in diffuse regions as well as single features. A point XANES measurement is shown in (b) which 
utilized a 3 µm beam on a region with high Cr signal. The spectrum shows close resemblance to CrPO4 
(also shown in b). 
XANES mapping reduced sampling bias, increased the size of the data set acquired and 
improved the quality of the spectroscopic data. A representative μXANES map possessing 
regions of both high and low intensity Co and Cr fluorescence (250 x 50 μm area taken from 
inset in Figure 1a) is shown in Figure 2. Principal component analysis identified four distinct 
spectra within the interrogated area (Figure 2). This method helps discriminate species present 
by summing pixels with similar spectral features, which is essential when investigating highly 
dilute samples. The high intensity regions (red) contained a larger contribution of metallic Cr 
than the surrounding regions, evident by the broader pre-peak at ~5995 eV. The surrounding 
clusters showed similar spectral features as the point XANES measurement shown in Figure 1. 
However, there were subtle difference at the post-edge peak, which were likely to be due to 
which Cr(III) species was present.
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Figure 2. A 3 μm resolution beam was utilized to generate a ~250 x 50 μm XANES map. Each point 
was grouped based on spectral similarities into four clusters. The resulting cluster map is shown in (a). 
The resulting spectra are shown in (b).
3.2. Sub micron- XANES/ XRF (600 nm resolution)
Subsequent imaging on the same tissue was performed using a higher resolution source at ID21. 
Figure 3a shows that at this resolution, while high intensity regions of Co and Cr are still seen, 
in comparison with the μXRF shown previously, it is more evident that Cr is present in areas 
without the presence of a Co counterpart completely. Quantitative values are summarised in 
Supplementary Table 2. This shows clear variability in the ratio of Co: Cr signal at a submicron 
level. Whilst this does not confirm speciation variability it shows that the degradation 
mechanism of these implants and/or the biological/ physiological modification in-situ, can 
produce metal features with significantly different Co: Cr ratios in the surrounding tissues 
compared with the base alloy. Figure 3b shows the region which was subsequently XANES 
mapped, highlighted by an inset in Figure 3a. Radial selections starting from the centre of a 
high intensity particle, moving outwards were summed, and are indicated within Figure 3b. A 
clear decrease in the pre-peak is observed whilst moving away from the centre of high intensity 
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(Figure 3c and 3d), indicating a reduction in metallic fraction. This was confirmed using linear 
combination fitting (LCF) of metallic-CoCr and Cr(III) complexes, including Cr(OH)3, Cr2O3 
and CrPO4 as standards (Supplementary Figure 2). To help identify which Cr(III) complexes 
were present, PCA analysis was conducted and a set of 4 clusters were generated and grouped 
based on spectral similarities (Figure 4). The most abundant cluster (1) is best represented as a 
combination of CrPO4, Cr(OH)3 and metallic-CoCr. These species are the most widely reported 
and therefore it is not surprising that they are the most abundant when undertaking a 
spectroscopic mapping approach. [35] Cluster 2 presents a difficult species to identify, a unique 
feature is observed at ~6025 eV which is present in all the contributing spectra. This feature 
cannot be explained from any of the organic Cr standards shown. Clusters 3 and 4 are also likely 
to be combinations of Cr(III) complexes with the highest fractions being Cr malate (C4H4CrO5) 
and Cr acetate hydroxide (Cr3(OH)2(OOCCH3)7), respectively. Regardless of the species 
observed, the spectral features of these components are significantly different from those seen 
when interrogating with a micron sized X-ray profile in a point spectrum fashion. To imitate 
the product of the high resolution XANES map recorded with a 3 μm resolution, a 5 x 5-pixel 
area was summed (Figure 5). The summed and single point spectra, shown in Figure 1b, both 
contain the broadened pre-peak characteristic of CoCr, and similar edge and post peak regions 
suggesting primarily CrPO4 content. The subtle intensity differences of the first interference 
peak between summed and single point spectra is likely to be due to dissimilar contributions 
from Cr(III) species at this location. Most importantly this shows that averaging over an area 
of heterogeneous speciation may not be an accurate representation of the species present. 
Supplementary Figures 3 and 4 summarize a statistical analysis of XANES spectra acquired 
using the different measurement approaches. Linear regression analyses applied to the Cr post-
edge region (6.00 – 6.04 keV) on the high-resolution ID21 XANES map data (600 x 600 nm 
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per pixel), identified that only ~50% of spectra were well-represented by the 3x3 µm2 average 
spectra of the entire measurement region (R2 > 0.9, p<0.05). Whilst XANES mapping at a 3 
µm resolution (Figure 2) indicated potential variation in the spectra identified by PCA, linear 
regression comparing the most different components failed to discriminate significant 
differences. As over 1400 spectra were analysed in the I18 XANES map alone (Figure 2) and 
insignificant variation was observed, this emphasises that the measurement spatial resolution 
limits characterisation of Cr speciation in these samples.
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Figure 3. sub-micron-XRF and XANES mapping analysis undertaken on ID21.  (a) shows a high 
resolution XRF map on the ex-vivo soft tissue (600 nm beam size). At this resolution it is more evident 
that CoCr features are present within a network of diffuse Cr. (b) shows an intensity map of the area 
subjected to Cr XANES mapping, highlighted by an inset in (a). To understand speciation variation 
across the high intensity CoCr regions, radial selections of the XANES spectra were taken, starting in 
the middle and moving outwards, the results are shown in (c). The pre-edge region, highlighted in (d), 
shows the further away from the centre of the feature causes a reduction in metallic fraction. (e) shows 
a histogram of how the metallic fraction reduces when moving away from the inside the core outwards 
(based off the pre-edge peak).
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Figure 4. Shows the cluster analysis of the XANES mapping data in the region identified in Figure 3. 
XANES data was stacked and aligned using in-house ID21 algorithms. Six principle components were 
identified but only 4 clusters were used as after this point the spectra could be reproduced using linear 
combinations of standards in different ratios. Each cluster is shown on a separate graph (solid black line) 
and Cr standards which are thought to contribute to the spectra are shown (dashed-line). Cluster 1 is the 
most abundant spectra and from the linear combination fitting (LCF) it is likely to be a combination of 
CrPO4, Cr(OH)3 and CoCr (34%, 41% and 25%, respectively. The spectrum in Cluster 2 contains a 
unique feature present at ~6025 eV which is not present in any of the organic or inorganic reference 
spectra. Cluster 3 and 4 are combinations of Cr complexes with CoCr, however a LCF is not shown as 
the predominate species present is Cr malate and acetate hydroxide, respectively.
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Figure 5. The two spectra shown on the right-hand side are a result of summing a 3x3 μm area from the 
XANES map, mimicking a lower resolution static measurement. By averaging over a larger area some 
spectral features are lost which may be essential for working out which species are present. The top 
region results in a spectrum with prominent features similar to Cr(OH)3 and CrPO4 complexes. The 
bottom region spectrum has a broader peak with no secondary peak, this feature is similar to those shown 
by organic Cr complexes.
3.3. Nano- XANES/ XRF (250 nm resolution)
XRF mapping, Co and Cr XANES were performed at the hard X-ray nanoprobe I14 (Diamond 
Light Source, UK), utilising a 250 nm X-ray beam. [52] Interrogating Co with a XANES mapping 
approach reduces the likelihood of X-ray induced oxidation by significantly reducing the X-ray 
exposure time per pixel. [53] The distribution of Co and Cr was similar to results recorded at 
ID21 (Figure 6a). A smaller region was subsequently imaged at 250 nm and the Co: Cr ratio 
was calculated (Figure 6b). To generate an accurate Co: Cr ratio map the data was considered 
in a semi-quantitative manner. The data outputted from XRF maps does not consider X-ray 
excitation efficiencies and sources of fluorescence attenuation throughout the sample. 
Deploying a semi-quantitative approach by accurately defining these parameters will enable 
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direct comparison of the relative element concentrations within a system. The exact 
concentration of each element cannot be reported without empirical calculation (with the use of 
calibration curves), utilising theoretical algorithms (with the use of reference materials) or using 
Monte-Carlo simulations. [54-58] Generating ratios from the RAW data resulted in some pixels 
exceeding a ratio of 3: 1 (Co: Cr). Whereas applying a quantitative approach the same pixels 
reduced to less than 2: 1, this ratio is more representative of the base alloy. The effects of 
analysing semi-quantitatively are summarised in Supplementary Figure 5. Less than 0.1% of 
pixels containing both Co and Cr had a ratio similar to that of the bulk alloy.
To attempt to get a full representation of the Co speciation, an area containing both high and 
low Co: Cr were selected for XANES mapping. Pixels containing more Co than Cr were 
grouped into the ‘high Co: Cr’ category and vice versa for the ‘low Co: Cr’ category. In both 
cases, and when looking at each feature separately, the Co species present appeared metallic 
with no traces of oxide or organic complexes within the interrogated region. Previous reports 
on similar metallic exposures have shown both the presence of Co in a metallic form as well as 
a Co(II) structure. [35, 59] In some of these previous cases the presence of an oxidized Co was 
attributed to the damaging effects of the beam exposure. [35] A XANES mapping approach 
reduces the exposure time significantly. The XRF maps were recorded at 100 ms per pixel with 
96 energy values, generating a total X-ray exposure time of 9.6 s per pixel spread across a time 
period > 2h. In contrast to previous reports, no Co oxide was seen in any of the XANES maps 
generated (equivalent of 7500 individual XANES spectra). The Cr species in areas with high 
Co: Cr contained a much larger fraction of metallic Cr (Figure 6d). Whereas in the Co deficient 
areas the pre-edge is lower, and a prominent secondary oscillation is present, characteristic of 
a Cr(III) complex such as the ones identified previously. Within this system there are features 
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that remain close to the original alloying composition and both Co and Cr XANES presented 
predominately metallic spectra. These findings indicate that high intensity regions of Co, Cr 
and Mo are likely to be in particulate form with predominately metallic chemistry appose to a 
soluble ionic species. However, there are regions where Cr features are Co deficient or even 
completely lacking a Co counterpart. This may be caused by dissolution of CoCr and 
reprecipitation locally as a stable Cr(III) complex, whilst Co is predominately observed as an 
ionic form and distributed systemically due to its increased solubility. [60] This is supported by 
elevated Co levels (compared with Cr) in patient‘s urine and blood with similar metallic 
prosthetics. [61, 62] The passive oxide surface of CoCr implant alloys consists largely of Cr2O3 
however, this layer is typically 2-5 nm in thickness which cannot explain the metals features 
observed which are several microns in diameter. [63, 64] Additionally, evidence collected from 
XANES demonstrates differences in chemistries expected to that of the native alloy. 
Irrespective of whether the metal derivatives are released from the bulk alloy, the surface oxide 
or modified to due corrosive mechanisms and/or biological/environmental processing, it is 
evident Co is deficient in most metal features observed within peri-implant tissues. The 
determining factor of whether Cr complexes or remains as a soluble ion is thought to be 
dependent on the local environment and availability of ligands and organic complexes. Whilst, 
the chemical form can be predicted based on relative elemental intensities, absorption 
spectroscopy is essential for validation of the exact speciation.
Understanding the chemistry of these metals is fundamental to understanding the mechanisms 
of their production and any associated processing upon leaving the implant surface. The 
speciation may also dictate the associated cellular behaviours, and thus be a contributing factor 
to the viability of the implant. Using more advanced spectroscopic techniques such as XANES 
mapping on these systems allows a larger area to be interrogated chemically, a higher number 
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of spectra to be recorded, improves the quality of data on isolated features, reduces the effects 
of beam exposure and generates a spatial aspect to the interpretation. By deploying a multi-
scale approach, it is evident that resolution is a fundamental aspect in interrogating the 
speciation of heterogeneous samples. A compromise between a higher resolution (allowing a 
greater discrimination between heterogeneous species) and a lower resolution (enabling larger 
areas to be interrogated) must be achieved.
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Figure 6. (a) XRF map of ex-vivo soft tissues recorded at the hard X-ray nano-probe I14. A step of 1 
µm was used both horizontally and vertically. The elements shown are Co (red), Cr (blue) and Fe (green). 
Fe was utilised to observe the tissue geometry as it contained the highest signal-to-noise of all the soft 
tissue elements present. (b) Co: Cr ratio map from area highlighted in Figure 6a, a resolution of 250 nm 
was used. Co (c) and Cr (d) XANES spectra from the XANES map region highlighted in Figure 6b. The 
spectra shown are a result of summing spectra based on their Co: Cr ratios. Spectra containing high Co: 
Cr are shown in black, whereas spectra containing low Co: Cr are shown in blue.
  
23
4. CONCLUSIONS
It has been demonstrated that, within tissues associated with CoCrMo metal-on-metal hip 
replacements, elemental and chemical variability at the nanomeric scale is observed. The 
distinctiveness of a XANES mapping approach is that it enables the entire chemical variability 
of an image field to be captured, as opposed to simply identifying which elements are present 
and measuring the speciation at single user defined points (reducing bias sampling). It is 
important to emphasise that a few point spectra with a broad (micron-sized) beam cannot 
represent the full chemical variability present within heterogeneous samples. In this case, a 
submicron level of detail with a mapping approach is an ideal interrogation method on such 
samples. In addition, small features (with sufficient intensity) have been interrogated yielding 
high-quality speciation information with a XANES mapping approach, which previously were 
difficult or impossible to record with conventional point XANES. Although this study 
highlights in particular, unreported heterogeneity in Cr speciation in peri-implant tissues 
associated with CoCrMo THRs, caution should be taken in over-interpretation of the findings 
with respect to correlations with clinical failures.  Investigating the range of metallic chemistry 
that patients are exposed to is imperative to understand the underlying immunological response, 
to generate more appropriate biological models and to aid the understanding of device failure. 
However, the reported approach should now be used in conjunction with adequate patient 
sample sizes to allow generalization of findings. 
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SUPPORTING INFORMATION 
Co-location of Mo with high intensity Co and Cr identifies metallic features most closely 
matching the composition of the base metal (Supplementary Figure 1). Linear combination 
fitting (LCF) of metallic-CoCr and Cr(III) complexes, including Cr(OH)3, Cr2O3 and CrPO4 as 
standards (Supplementary Figure 2). The effects of X-ray resolution in identifying the Cr 
chemistry is shown (Supplementary Figure 3). Linear regression analysis identifies the range 
of post-edge variation between high-resolution XANES the average spectrum and a cross-
correlation analysis between different data sets (Supplementary Figure 4). Semi-quantitative 
analysis of CoCr distributions (Supplementary Figure 5). Details of sequential energy points 
used for XANES mapping (Supplementary Table 1). A quantitative summary of Co and Cr 
within images recorded at I18 and ID21 is listed (Supplementary Table 2).
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Figure 1. μXRF and µXANES analysis was undertaken at I18, Diamond Light Source, UK.  (a) shows 
an XRF map of ex-vivo synovial sheath tissue, Cl (green) is a typical tissue marker and shows the 
geometry. Co and Cr (red and blue respectively) are co-located in areas but Cr appears more abundantly 
and in diffuse regions as well as single features. A point XANES measurement is shown in (b) which 
utilized a 3 µm beam on a region with high Cr signal. The spectrum shows close resemblance to CrPO4 
(also shown in b). 
Figure 2. A 3 μm resolution beam was utilized to generate a ~250 x 50 μm XANES map. Each point 
was grouped based on spectral similarities into four clusters. The resulting cluster map is shown in (a). 
The resulting spectra are shown in (b).
Figure 3. sub-micron-XRF and XANES mapping analysis undertaken on ID21.  (a) shows a high 
resolution XRF map on the ex-vivo soft tissue (600 nm beam size). At this resolution it is more evident 
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that CoCr features are present within a network of diffuse Cr. (b) shows an intensity map of the area 
subjected to Cr XANES mapping, highlighted by an inset in (a). To understand speciation variation 
across the high intensity CoCr regions, radial selections of the XANES spectra were taken, starting in 
the middle and moving outwards, the results are shown in (c). The pre-edge region, highlighted in (d), 
shows the further away from the centre of the feature causes a reduction in metallic fraction. (e) shows 
a histogram of how the metallic fraction reduces when moving away from the inside the core outwards 
(based off the pre-edge peak).
Figure 4. Shows the cluster analysis of the XANES mapping data in the region identified in Figure 3. 
XANES data was stacked and aligned using in-house ID21 algorithms. Six principle components were 
identified but only 4 clusters were used as after this point the spectra could be reproduced using linear 
combinations of standards in different ratios. Each cluster is shown on a separate graph (solid black line) 
and Cr standards which are thought to contribute to the spectra are shown (dashed-line). Cluster 1 is the 
most abundant spectra and from the linear combination fitting (LCF) it is likely to be a combination of 
CrPO4, Cr(OH)3 and CoCr (34%, 41% and 25%, respectively. The spectrum in Cluster 2 contains a 
unique feature present at ~6025 eV which is not present in any of the organic or inorganic reference 
spectra. Cluster 3 and 4 are combinations of Cr complexes with CoCr, however a LCF is not shown as 
the predominate species present is Cr malate and acetate hydroxide, respectively.
Figure 5. The two spectra shown on the right-hand side are a result of summing a 3x3 μm area from the 
XANES map, mimicking a lower resolution static measurement. By averaging over a larger area some 
spectral features are lost which may be essential for working out which species are present. The top 
region results in a spectrum with prominent features similar to Cr(OH)3 and CrPO4 complexes. The 
bottom region spectrum has a broader peak with no secondary peak, this feature is similar to those shown 
by organic Cr complexes.
Figure 6. (a) XRF map of ex-vivo soft tissues recorded at the hard X-ray nano-probe I14. A step of 1 
µm was used both horizontally and vertically. The elements shown are Co (red), Cr (blue) and Fe (green). 
Fe was utilised to observe the tissue geometry as it contained the highest signal-to-noise of all the soft 
tissue elements present. (b) Co: Cr ratio map from area highlighted in Figure 6a, a resolution of 250 nm 
was used. Co (c) and Cr (d) XANES spectra from the XANES map region highlighted in Figure 6b. The 
spectra shown are a result of summing spectra based on their Co: Cr ratios. Spectra containing high Co: 
Cr are shown in black, whereas spectra containing low Co: Cr are shown in blue.
Supplementary Figure 1. A matching tissue section was subsequently imaged at the Swiss Light 
Source (SLS) at the Paul Scherrer Institute (Villigen, Switzerland). A resolution of 1 μm was used at the 
MicroXAS beamline with a 20.2 keV X-ray energy to detect Mo. An acquisition time of 1 s per point 
was used to generate two maps in different locations (a high Co region and high Cr region). Molybdenum 
was found in all cases and showed a high correlation with Co (a) and Cr (b).
Supplementary Figure 2. Linear combination fittings for the radial selections shown in Figure 3c (1-4 
left to right). Data and their respective fits are shown as the black and red traces respectively. Software 
package ATHENA was used to generate the LCF on normalized spectra. The fit was limited to 15eV 
below and 21eV above the absorption edge and the E0 of the standards was kept constant. CrCo was 
used as the metallic portion with CrPO4, Cr(OH)3, Cr2O3 and Cr acetate hydroxide as the Cr complex. 
The fit on radial selection 2 deviates from the data more than the other selections. This was due to a 
number of spectra within the selection containing unique spectral features which could not be 
reproduced with the Cr standards available.
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Supplementary Figure 3. Illustration of the spectral variation observed in Figure 5a. The spectra 
generated through XANES mapping were grouped based on post-edge similarities. Six groups indicative 
of the variation in Cr speciation are compared with the average spectrum of the 3 x 3 μm measurement 
area (25-pixel average) and demonstrates that a reduced resolution measurement under-estimates the 
range of Cr species present within these ex-vivo tissues.
Supplementary Figure 4. (a) Linear regression analysis was applied to the post-edge region (6.00 – 
6.04 keV) on the high-resolution XANES map data and is compared with the 25-pixel average in Figure 
5a. This energy domain was selected as typically variation here indicates differences in Cr(III) speciation. 
The R2 values are shown and in all cases p < 0.05. Only half of the spectra observed are well-represented 
by the 3x3 µm2 average (R2 > 0.9) (b) Linear regression analysis was used to cross-correlate XANES 
spectra acquired using different measurement approaches (point spectra vs mapping at different spatial 
resolutions). For equivalent measurement areas (3x3 µm2) the 25-pixel average (equivalent area), 
measured at ID21 correlated strongly (R2=0.986) with the 3x3 µm point XANES measured at I18 (A). 
Both of which have high correlative values with a CrPO4 standard (B) which is the most frequently 
reported Cr species in tissues associated with THR systems. Whilst XANES mapping at a 3 µm 
resolution (Figure 2) showed variation in the spectra identified by PCA, linear regression comparing the 
most different components (cluster 1 (C) and 4 (D)) fails to discriminate significant differences. As over 
1400 spectra were analysed in the I18 XANES map alone and insignificant variation was observed, this 
emphasises that the resolution is limiting factor in the characterisation of Cr speciation in these samples.
Supplementary Figure 5. (a) and (b) are ratio maps (250 nm resolution) from an area within Figure 6a. 
The analysis of (a) has been treated qualitatively, using only the number of counts to determine the 
ratios. Whereas the analysis of (b) has been considered semi-quantitatively considering the differences 
in attenuation of Co and Cr due to the different wavelengths. Both (a) and (b) are plotted using the same 
colour scale to allow direct comparison. (c) shows the resulting ratio distribution in a histogram, the 
blue plot represents the qualitative analysis (a), the red plot represents the semi-quantitative analysis 
(b). It is clear from these results the Co: Cr ratios are significantly lower when analysing semi-
quantitatively, which are deemed more accurate.
SIGNIFICANCE
Metal implants are routinely used in healthcare but may fail following degradation in the body. 
Although specific implants can be identified as ‘high-risk’, our analysis of failures is limited 
by a lack of understanding of the chemistry of implant metals within the peri-prosthetic milieu. 
A new approach to identify the speciation and variability in speciation at sub-micron resolution, 
of dilute exogenous metals within biological tissues is reported; applied to understanding the 
failure of metallic (CoCrMo) total-hip-replacements widely used in orthopedic surgery. Much 
greater variation in Cr chemistry was observed compared with previous reports and included 
phosphate, hydroxide, oxide, metal and organic complexes. This variability may explain lack 
of agreement between biological responses observed in experimental exposure models and 
clinical outcomes.
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